CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar Kid6521 (< 20) Submitted: 10/24/2009 10:32:37 AM : Outperform Start Price: $7.21 CRY Score: -58.15

This company will rebound

Featured Broker Partners


Advertisement